Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trialDavid M. Charytan, Jonathan Himmelfarb, T. Alp İkizler et al.|Kidney International|2018Cited by 104